Baseline Mycobacterial Immune Responses in HIV‐Infected Adults Primed with bacille Calmette‐Guérin during Childhood and Entering a Tuberculosis Booster Vaccine Trial
Author(s) -
Mecky Matee,
Timothy Lahey,
Jenni M. Vuola,
Lillian Mtei,
Bernard F. Cole,
Muhammad Bakari,
R. D. Arbeit,
C. Robert Horsburgh,
Kisali Pallangyo,
C. Fordham von Reyn
Publication year - 2006
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/509896
Subject(s) - immunology , tuberculosis , mycobacterium tuberculosis , medicine , immune system , antigen , tuberculosis vaccines , booster dose , virology , immunization , pathology
Most new tuberculosis vaccines will be administered as a booster to subjects primed with bacille Calmette-Guérin (BCG) during childhood.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom